H. Caffier
About
In The Last Decade
H. Caffier
38 papers receiving 616 citations
Peers
Comparison fields: 5 of 77
- Molecular Biology 332
- Oncology 216
- Genetics 187
- Cancer Research 157
- Reproductive Medicine 137
Countries citing papers authored by H. Caffier
This map shows the geographic impact of H. Caffier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Caffier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Caffier more than expected).
Fields of papers citing papers by H. Caffier
This network shows the impact of papers produced by H. Caffier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Caffier. The network helps show where H. Caffier may publish in the future.
Co-authorship network of co-authors of H. Caffier
This figure shows the co-authorship network connecting the top 25 collaborators of H. Caffier. A scholar is included among the top collaborators of H. Caffier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Caffier. H. Caffier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | The clinicopathological and prognostic relevance of pyruvate kinase M2 and pAkt expression in breast cancer. | 30 |
| 2 | 3 | |
| 3 | 0 | |
| 4 | The correlation of c-erbB-2 oncoprotein and established prognostic factors in human breast cancer. | 7 |
| 5 | Prognostic relevance of the endothelial marker CD 34 in ovarian cancer. | 42 |
| 6 | Diagnostic value of serum VEGF in women with ovarian tumors. | 32 |
| 7 | 31 | |
| 8 | 31 | |
| 9 | 4 | |
| 10 | 34 | |
| 11 | 24 | |
| 12 | Clinical value of CYFRA 8/18 and TPS in the diagnosis and follow up of invasive breast cancer. | 4 |
| 13 | Correlation of the EGF-receptor with cell kinetic and classical prognostic factors in breast cancer. | 11 |
| 14 | 10 | |
| 15 | 43 | |
| 16 | 6 | |
| 17 | 0 | |
| 18 | 0 | |
| 19 | 45 | |
| 20 | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.